Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087177453> ?p ?o ?g. }
Showing items 1 to 70 of
70
with 100 items per page.
- W2087177453 endingPage "O17" @default.
- W2087177453 startingPage "O17" @default.
- W2087177453 abstract "By the end of June 2012 NOS News got hold of a concept advice to the Minister of Health. It proposed to stop the reimbursement of the orphan drugs Myozyme against Pompe’s disease and Fabryzyme and Replagal against Fabry’s disease. All three enzyme-therapies are very expensive. The treatment for Pompe-patients costs roughly between € 400.000 and € 700.000 a year, for Fabry-patients about € 220.000 a year. The main argument for stopping the compensation was the cost-ineffectiveness of the enzyme-therapy. In other words: too much money for too little result.The concept advice was written by the CVZ, the main advisor of the Minister on the health-insurance. The Pompe and Fabry enzyme-therapies got insurance-coverage for a limited periode of four years beginning 2009. The registration by the EMA was based on very limited evidence.The proposal to stop the reimbursement of Pompe and Fabry therapies – only babies with the classical form of Pompe would keep the compensation - , was the first ever of this kind. There is no alternative treatment available. And no patient can afford to pay hundreds of thousands of euros year after year.We realised that this proposal crossed a unique line. Until 2012 CVZ refused the reimbursement of several drugs. In the field of chronic diseases, for example, not every new drug is automatically reimbursed. But there are always alternatives that are. Not in this case.We tried to publish this story with all parties concerned: the patients and their organisations, the doctors specialized in Pompe and Fabry diseases, the CVZ, the Health Ministry. They all refused to comment. For five weeks we tried to convince them, before we published without their consent.At first the messenger was blamed for the bad news. In the end we were hailed for preventing this plan to become reality. From July 2012 until October 2013 we closely followed the decision making process. We attended hearings where everybody had the opportunity to try to convince the CVZ to change its views.The CVZ refused to withdraw its proposal, but finally made a U-turn and advised the Minister to maintain the reimbursement of the therapies for all patients. The patients and their relatives were relieved. One could argue that common decency won.But the real problem remains unsolved. Why are these enzyme-therapies so expensive? Why are they so mediocre? Is it true that the industry lacks incentives to come up with a better product since the limited one generates such a substantial amount of money?" @default.
- W2087177453 created "2016-06-24" @default.
- W2087177453 creator A5029555130 @default.
- W2087177453 date "2014-01-01" @default.
- W2087177453 modified "2023-09-25" @default.
- W2087177453 title "Reimbursement of orphan drugs: the Pompe and Fabry case in the Netherlands" @default.
- W2087177453 doi "https://doi.org/10.1186/1750-1172-9-s1-o17" @default.
- W2087177453 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4249602" @default.
- W2087177453 hasPublicationYear "2014" @default.
- W2087177453 type Work @default.
- W2087177453 sameAs 2087177453 @default.
- W2087177453 citedByCount "3" @default.
- W2087177453 countsByYear W20871774532016 @default.
- W2087177453 countsByYear W20871774532020 @default.
- W2087177453 countsByYear W20871774532022 @default.
- W2087177453 crossrefType "journal-article" @default.
- W2087177453 hasAuthorship W2087177453A5029555130 @default.
- W2087177453 hasBestOaLocation W20871774531 @default.
- W2087177453 hasConcept C104317684 @default.
- W2087177453 hasConcept C126322002 @default.
- W2087177453 hasConcept C160735492 @default.
- W2087177453 hasConcept C162324750 @default.
- W2087177453 hasConcept C2777404818 @default.
- W2087177453 hasConcept C2779134260 @default.
- W2087177453 hasConcept C2779703844 @default.
- W2087177453 hasConcept C2779969927 @default.
- W2087177453 hasConcept C47042493 @default.
- W2087177453 hasConcept C50522688 @default.
- W2087177453 hasConcept C54355233 @default.
- W2087177453 hasConcept C60644358 @default.
- W2087177453 hasConcept C71924100 @default.
- W2087177453 hasConcept C75480439 @default.
- W2087177453 hasConcept C86803240 @default.
- W2087177453 hasConceptScore W2087177453C104317684 @default.
- W2087177453 hasConceptScore W2087177453C126322002 @default.
- W2087177453 hasConceptScore W2087177453C160735492 @default.
- W2087177453 hasConceptScore W2087177453C162324750 @default.
- W2087177453 hasConceptScore W2087177453C2777404818 @default.
- W2087177453 hasConceptScore W2087177453C2779134260 @default.
- W2087177453 hasConceptScore W2087177453C2779703844 @default.
- W2087177453 hasConceptScore W2087177453C2779969927 @default.
- W2087177453 hasConceptScore W2087177453C47042493 @default.
- W2087177453 hasConceptScore W2087177453C50522688 @default.
- W2087177453 hasConceptScore W2087177453C54355233 @default.
- W2087177453 hasConceptScore W2087177453C60644358 @default.
- W2087177453 hasConceptScore W2087177453C71924100 @default.
- W2087177453 hasConceptScore W2087177453C75480439 @default.
- W2087177453 hasConceptScore W2087177453C86803240 @default.
- W2087177453 hasIssue "Suppl 1" @default.
- W2087177453 hasLocation W20871774531 @default.
- W2087177453 hasLocation W20871774532 @default.
- W2087177453 hasOpenAccess W2087177453 @default.
- W2087177453 hasPrimaryLocation W20871774531 @default.
- W2087177453 hasRelatedWork W1854404930 @default.
- W2087177453 hasRelatedWork W1980392051 @default.
- W2087177453 hasRelatedWork W2079324568 @default.
- W2087177453 hasRelatedWork W2087177453 @default.
- W2087177453 hasRelatedWork W2125045778 @default.
- W2087177453 hasRelatedWork W2170467794 @default.
- W2087177453 hasRelatedWork W3008656384 @default.
- W2087177453 hasRelatedWork W3014351174 @default.
- W2087177453 hasRelatedWork W89640856 @default.
- W2087177453 hasRelatedWork W2610613177 @default.
- W2087177453 hasVolume "9" @default.
- W2087177453 isParatext "false" @default.
- W2087177453 isRetracted "false" @default.
- W2087177453 magId "2087177453" @default.
- W2087177453 workType "article" @default.